PIPERACILLIN AND TAZOBACTAM FOR INJECTION

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: fb35b50585d6b2e9
Drug Approval Canada Name: PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Product Name: PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Status: Cancelled Post Market
Status Date: 2025-06-10
Original Market Date: 2022-01-06
Din: 02465833
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:12.16.16
Atc Original: J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name: j 01 cr 05
Aig Number: 0225919008
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

PIPERACILLIN (PIPERACILLIN SODIUM)

36 G / VIAL

TAZOBACTAM (TAZOBACTAM SODIUM)

4.5 G / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fb35b50585d6b2e9

Type

Standard